BMS 250MG 6673 (Videx EC 250 mg)
Generic Name: didanosine
Pill imprint BMS 250MG 6673 has been identified as Videx EC 250 mg.
Videx EC is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Videx EC 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- didanosine
- Imprint:
- BMS 250MG 6673
- Strength:
- 250 mg
- Color:
- White
- Size:
- 19.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00087-6673
- Inactive Ingredients:
- carboxymethylcellulose sodium
diethyl phthalate
methacrylic acid - methyl methacrylate copolymer (1:2)
sodium hydroxide
sodium starch glycolate type A potato
magnesium silicate
gelatin
titanium dioxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-5504 | A-S Medication Solutions, LLC (repackager) |
| 54868-5595 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
More about Videx EC (didanosine)
Consumer resources
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
